Insider buying last 90 days
No open-market insider purchases were filed for CWK in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
This week's stock move centers on Cushman & Wakefield's continued reaction to its Q2 2026 results and a ratings action. The stock touched a 52-week low of $11.52 even as the company reported revenue up 11% to $2.76 billion, adjusted EPS rising 17% to $0.35, and a raised full-year adjusted EPS growth guidance, alongside reduced net debt. Separately, S&P Global Ratings upgraded Cushman & Wakefield's issuer credit rating to 'BB' from 'BB-', citing recovering commercial real estate activity and debt reduction progress.
CWK closed at $11.55, down 0.6%, sitting below both its 50-day average of $13.16 and 200-day average of $13.71, with the 50-day below the 200-day. The GekkoIndex reads 66.1, placing the stock in the Accumulation zone. Price sits 47.6% below Gekko Fair Value of $22.05, a wide gap relative to current levels.
Earnings are scheduled for 29 October 2026, 17 days away, falling inside a typical 20-trading-day holding window; the prior report showed an EPS beat with a -3% reaction despite six consecutive quarters of double-digit EPS growth. No insider, Congress, or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 6.5% return over 5 years, rising in 4 of them. Consensus among 6 firms stands at 3 buy and 3 hold ratings, with a consensus target of $17.73.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Cushman & Wakefield scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
Below 50 and 200-day
Close $11.55 is below the 50-day ($13.16) and 200-day ($13.71) averages, and the 50-day is below the 200-day.
See the chart66.1, Accumulation
Reading 66.1 is in the Accumulation zone.
See the GekkoIndex47.6% below
Price is 47.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 17 days
Reports on Oct 29, 2026, 17 days away — inside a typical 20-trading-day hold.
See earnings+6.5% on average
From this point in the calendar, the next 20 trading days averaged +6.5% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Cushman & Wakefield closed at $11.55 on Oct 12, 2026, −22.3% over the past year, inside a 52-week range of $11.15 to $17.40.
Use the left and right arrow keys to read daily values.
Put CWK on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Cushman & Wakefield works in commercial real estate, offering services that help property owners and occupiers manage, lease, value, and finance their holdings. Its work spans property and facilities oversight, project management, leasing arrangements, capital markets activity, and valuation work, making it a service provider across many stages of a property's lifecycle.
The firm serves both landlords and tenants, acting as an intermediary and advisor for real estate decisions of various kinds. Its reach extends across multiple regions, with operations covering the Americas, Europe, the Middle East, Africa, and Asia Pacific, allowing it to support clients with property interests in different parts of the world.
Shares of Cushman & Wakefield are listed on the NYSE under the ticker CWK.
Cushman & Wakefield’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.1, in the Accumulation zone, down 5.7 points over five sessions.
Down 5.7 points over five sessions, from the Buying zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 33 | −0.3% | +1.8% | ||
| Accumulation (current zone) | 198 | +0.9% | +3.8% | ||
| Neutral | 405 | +0.2% | 0.0% | ||
| Distribution | 45 | −0.7% | +1.7% | ||
| Selling | 1 | Too few readings yet | |||
Average CWK share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Cushman & Wakefield trades 47.6% below Gekko Fair Value of $22.05, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cushman & Wakefield shares are worth, recalculated every trading day.
$22.05
Gekko Fair Value, Oct 9, 2026
47.6% Undervalued
No open-market insider purchases were filed for Cushman & Wakefield, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CWK in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CWK were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Cushman & Wakefield has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold CWK.
Cushman & Wakefield reports on Oct 29, 2026 (17 days away), and beat the EPS estimate in 6 of its last 8 reports.
Oct 29, 2026
17 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 5, 2026 | $0.35 est $0.36 | $2.76B est $2.65B | −3.0% |
| May 7, 2026 | $0.15 est $0.13 | $2.54B est $2.29B | −1.9% |
| Feb 19, 2026 | $0.54 est $0.54 | $2.04B est $2.01B | −1.7% |
| Oct 30, 2025 | $0.29 est $0.28 | $2.61B est $2.82B | −5.0% |
| Aug 5, 2025 | $0.30 est $0.22 | $2.48B est $2.47B | +11.0% |
| Apr 29, 2025 | $0.09 est $0.02 | $1.54B est $1.55B | +4.0% |
| Feb 20, 2025 | $0.48 est $0.48 | $2.63B est $2.24B | −10.6% |
| Nov 4, 2024 | $0.23 est $0.21 | — | +16.4% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Cushman & Wakefield is $17.73, +53.5% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 1 | J.P. Morgan | $19 | +64.5% |
| Aug 18 | Goldman Sachs | $19 | +64.5% |
| Aug 17 | Barclays | $16 | +38.5% |
| Aug 10 | UBS | $15 | +29.9% |
| Aug 6 | Barclays | $15 | +29.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Cushman & Wakefield averaged +6.5% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.7% | 4 of 5 |
| Next 10 trading days | +1.8% | 4 of 5 |
| Next 15 trading days | +3.0% | 3 of 5 |
| Next 20 trading days | +6.5% | 4 of 5 |
| Next 30 trading days | +6.3% | 4 of 5 |
For scale, CWK’s typical 20-trading-day move in either direction is about 8.2%.
Cushman & Wakefield’s market cap is $2.71B, with a P/E ratio of 39.4 and revenue of $10.82B over the last twelve months.
Coverage of Cushman & Wakefield this week reads positive: 2 positive, 2 neutral and 0 negative headlines.
Cushman & Wakefield’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| CBRECBRE | Accumulation | 0.4% below |
| JLLJones Lang LaSalle | Accumulation | 22.8% below |
| FSVFirstService | Accumulation | 5.2% below |
| HHHHoward Hughes | Neutral | 13.5% above |
| MTHMeritage Homes | Buying | 33.3% below |
| JOESt. Joe | Neutral | 20.9% above |
A peer links to its own page where one exists.
Cushman & Wakefield’s market cap is $2.71B at the Oct 12, 2026 close of $11.55, with 234.7M shares outstanding. The shares trade on a P/E ratio of 39.4.
The consensus analyst 12-month price target for Cushman & Wakefield is $17.73, +53.5% from the last close. Of the 6 firms that rated the stock in the last 90 days, 3 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Cushman & Wakefield is undervalued: the Oct 12, 2026 close of $11.55 is 47.6% below Gekko Fair Value of $22.05. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Cushman & Wakefield is expected to report on Oct 29, 2026 (17 days away). Analysts expect earnings of $0.35 per share on revenue of $2.78B. Cushman & Wakefield beat the earnings estimate in 6 of its last 8 reports, moving 6.7% on average across the report.
Cushman & Wakefield’s 52-week high is $17.40 and its 52-week low is $11.15; it closed at $11.55 on Oct 12, 2026, −22.3% over the past year. Over the last five years the shares peaked at $23.54 on Feb 25, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality) and 2 as headwinds (trend and earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.